A Multiple Ascending Dose Study of COR388

Summary

The study is a randomized, double-blind, placebo-controlled, multiple ascending dose study to assess the safety and tolerability of ascending repeat doses of COR388 HCl in older healthy male and female subjects and a cohort of Alzheimer's disease subjects.

Timeline

Start

2018-03-06

Primary completion

2018-10-15

Completion

2018-10-15

Drugs

Indications